BR9914835A - Proteìna e seus sais, método para fabricar a mesma, anticorpo para a mesma, ligando à mesma, método para determinar o mesmo, peptìdeo parcial da proteìna ou seus ésteres ou suas amidas ou seus sais, polinucleotìdeo, vetor recombinante, transformante, composição de diagnóstico, composição farmacêutica, composto ou seus sais, método para triar o mesmo, kit para triar o mesmo, método para quantificar a proteìna, peptìdeo, uma amida deste, um éster deste ou um sal deste, amida ou sal do peptìdeo, método para triagem, e, kit para filtragem - Google Patents

Proteìna e seus sais, método para fabricar a mesma, anticorpo para a mesma, ligando à mesma, método para determinar o mesmo, peptìdeo parcial da proteìna ou seus ésteres ou suas amidas ou seus sais, polinucleotìdeo, vetor recombinante, transformante, composição de diagnóstico, composição farmacêutica, composto ou seus sais, método para triar o mesmo, kit para triar o mesmo, método para quantificar a proteìna, peptìdeo, uma amida deste, um éster deste ou um sal deste, amida ou sal do peptìdeo, método para triagem, e, kit para filtragem

Info

Publication number
BR9914835A
BR9914835A BR9914835-8A BR9914835A BR9914835A BR 9914835 A BR9914835 A BR 9914835A BR 9914835 A BR9914835 A BR 9914835A BR 9914835 A BR9914835 A BR 9914835A
Authority
BR
Brazil
Prior art keywords
protein
salts
screening
peptide
kit
Prior art date
Application number
BR9914835-8A
Other languages
English (en)
Portuguese (pt)
Inventor
Takuya Watanabe
Yasuko Terao
Yasushi Shintani
Tetsuya Ohtaki
Kimiko Kanehashi
Chieko Kitada
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of BR9914835A publication Critical patent/BR9914835A/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Pathology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Pregnancy & Childbirth (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Peptides Or Proteins (AREA)
BR9914835-8A 1998-10-27 1999-10-26 Proteìna e seus sais, método para fabricar a mesma, anticorpo para a mesma, ligando à mesma, método para determinar o mesmo, peptìdeo parcial da proteìna ou seus ésteres ou suas amidas ou seus sais, polinucleotìdeo, vetor recombinante, transformante, composição de diagnóstico, composição farmacêutica, composto ou seus sais, método para triar o mesmo, kit para triar o mesmo, método para quantificar a proteìna, peptìdeo, uma amida deste, um éster deste ou um sal deste, amida ou sal do peptìdeo, método para triagem, e, kit para filtragem BR9914835A (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP30594998 1998-10-27
JP2771099 1999-02-04
JP5720799 1999-03-04
JP27622599A JP4486187B2 (ja) 1998-10-27 1999-09-29 新規ｇ蛋白質共役型レセプター蛋白質、そのｄｎａおよびそのリガンド
PCT/JP1999/005905 WO2000024890A1 (en) 1998-10-27 1999-10-26 Novel g protein-coupled receptor proteins, dnas thereof and ligands to the same

Publications (1)

Publication Number Publication Date
BR9914835A true BR9914835A (pt) 2002-06-18

Family

ID=27458743

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9914835-8A BR9914835A (pt) 1998-10-27 1999-10-26 Proteìna e seus sais, método para fabricar a mesma, anticorpo para a mesma, ligando à mesma, método para determinar o mesmo, peptìdeo parcial da proteìna ou seus ésteres ou suas amidas ou seus sais, polinucleotìdeo, vetor recombinante, transformante, composição de diagnóstico, composição farmacêutica, composto ou seus sais, método para triar o mesmo, kit para triar o mesmo, método para quantificar a proteìna, peptìdeo, uma amida deste, um éster deste ou um sal deste, amida ou sal do peptìdeo, método para triagem, e, kit para filtragem

Country Status (19)

Country Link
US (3) US6699965B1 (2)
EP (1) EP1126028B1 (2)
JP (1) JP4486187B2 (2)
KR (1) KR20010085974A (2)
CN (1) CN1324405A (2)
AT (1) ATE394485T1 (2)
AU (1) AU6230699A (2)
BR (1) BR9914835A (2)
CA (1) CA2347294A1 (2)
CZ (1) CZ20011358A3 (2)
DE (1) DE69938666D1 (2)
HU (1) HUP0104937A2 (2)
ID (1) ID28288A (2)
IL (1) IL142428A0 (2)
NO (1) NO20012059L (2)
NZ (1) NZ510977A (2)
PL (1) PL347553A1 (2)
SK (1) SK5502001A3 (2)
WO (1) WO2000024890A1 (2)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002536989A (ja) * 1999-02-24 2002-11-05 メルク エンド カムパニー インコーポレーテッド ガラニン受容体と類似したｇタンパク質共役受容体
US20050240008A1 (en) * 2000-03-30 2005-10-27 Tetsuya Ohtaki Novel protein, dna thereof and process for producing the same
EP1168259A3 (en) 2000-06-28 2003-12-17 Hitachi, Ltd. Data management method and system for IC card
JP4762481B2 (ja) 2000-08-30 2011-08-31 株式会社セルフリーサイエンス 無細胞タンパク質合成用転写鋳型の設計および構築、並びにこれを用いる希釈バッチ方式コムギ胚芽無細胞タンパク質合成法
JP2002109169A (ja) 2000-09-29 2002-04-12 Hitachi Ltd 作業支援方法並びにシステム及び作業支援方法を記録した記録媒体
CA2430934C (en) 2000-12-01 2011-06-21 Takeda Chemical Industries, Ltd. A method of producing sustained-release preparations of a bioactive substance using high-pressure gas
CA2431522A1 (en) * 2000-12-18 2002-08-01 Merck & Co. Inc. Isolated nucleic acid molecules encoding a human and mouse g protein-coupled receptor - gpr54; encoded proteins, cells transformed therewith and uses thereof
WO2002057309A1 (fr) * 2001-01-18 2002-07-25 Takeda Chemical Industries, Ltd. Nouvelle proteine receptrice couplee a la proteine g et adn de cette proteine
WO2002072816A1 (fr) * 2001-02-26 2002-09-19 Takeda Chemical Industries, Ltd. Proteine de recepteur murin de type kiss-1 et adn correspondant
WO2002083735A1 (fr) * 2001-04-06 2002-10-24 Takeda Chemical Industries, Ltd. Nouvelle proteine receptrice et son adn
AU2008202004A1 (en) * 2001-09-18 2008-05-29 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
EP1487877B1 (en) * 2001-09-18 2010-10-27 Genentech, Inc. Compositions and methods for the diagnosis of tumors
DE60219645T2 (de) 2001-09-19 2007-08-09 Takeda Pharmaceutical Co. Ltd. Antikörper gegen metastin und dessen verwendung zur diagnose von schwangerschaft
US20050176091A1 (en) * 2002-01-11 2005-08-11 Takao Yamada Process for producing kiss-1 peptide
EP2116551A1 (en) * 2002-09-11 2009-11-11 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
US20060241051A1 (en) 2002-12-26 2006-10-26 Chieko Kitada Metastin derivatives and use thereof
US6800611B2 (en) * 2003-01-06 2004-10-05 Takeda Chemical Industries, Ltd. Metastin derivatives and their use
WO2004080479A1 (ja) * 2003-03-12 2004-09-23 Takeda Pharmaceutical Company Limited 性腺機能改善剤
JP4639052B2 (ja) * 2003-03-12 2011-02-23 武田薬品工業株式会社 性腺機能改善剤
EP1464652A1 (en) * 2003-04-02 2004-10-06 Institut National De La Sante Et De La Recherche Medicale (Inserm) GPR54 receptor agonist and antagonist useful for the treatment of gonadotropin related diseases
WO2004096855A2 (en) * 2003-04-28 2004-11-11 Wyeth Methods utilising g-protein coupled receptor 54
WO2004101747A2 (en) * 2003-05-07 2004-11-25 The General Hospital Corporation Identification and use of gpr54 and its ligands for reproductive disorders and contraception
WO2005040833A1 (en) * 2003-10-21 2005-05-06 Bayer Healthcare Ag Regulation of human metastin recognising receptors
AR049938A1 (es) 2004-06-25 2006-09-13 Takeda Pharmaceutical Derivados de metastina y utilizacion de los mismos
TWI386417B (zh) 2005-12-22 2013-02-21 Takeda Pharmaceutical 轉移抑素衍生物及其用途
US20090099334A1 (en) * 2005-12-22 2009-04-16 Takeda Pharmaceutical Company Limited Metastin derivatives and use thereof
US8404643B2 (en) 2005-12-22 2013-03-26 Takeda Pharmaceutical Company Limited Metastin derivatives and use thereof
ITMI20061607A1 (it) 2006-08-09 2008-02-10 Maria Vincenza Carriero Peptidi con attivita farmacologica
TWI404726B (zh) 2006-10-25 2013-08-11 Takeda Pharmaceutical 腫瘤轉移抑制素衍生物及其用途
WO2009131191A1 (ja) * 2008-04-24 2009-10-29 武田薬品工業株式会社 メタスチン誘導体およびその用途
PT2314609T (pt) 2008-07-30 2017-03-06 Takeda Pharmaceuticals Co Derivado de metastina e sua utilização
EP2341942A1 (en) 2008-09-19 2011-07-13 Nektar Therapeutics Polymer conjugates of therapeutic peptides
US20110171160A1 (en) * 2008-09-19 2011-07-14 Nektar Therapeutics Polymer conjugates of kiss1 peptides
WO2010137022A1 (en) 2009-05-27 2010-12-02 Yeda Research And Development Co. Ltd Gpr54 agonists or antagonists for treatment of diseases presenting behavioral abnormalities
EP2873422A4 (en) 2012-07-10 2015-12-30 Takeda Pharmaceutical PHARMACEUTICAL PREPARATION FOR INJECTION
TWI810193B (zh) 2017-07-05 2023-08-01 大陸商尚華醫藥科技（江西）有限公司 一種Kiss1肽類化合物、其應用及含其的組合物
CN109212217B (zh) * 2018-11-07 2021-09-10 李玉民 基于amy1a蛋白胃癌检测试剂盒及其使用方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5436155A (en) * 1991-12-31 1995-07-25 Arch Development Corporation Isolated DNA encoding a somatostatin receptor
WO1996005302A1 (en) 1994-08-11 1996-02-22 Takeda Chemical Industries, Ltd. G protein coupled receptor protein, production, and use thereof
WO1997013778A1 (en) 1995-10-11 1997-04-17 The Penn State Research Foundation A metastasis suppressor gene
US6010877A (en) * 1997-01-10 2000-01-04 Smithkline Beecham Corporation cDNA clone HE8CS41 that encodes a novel 7-transmembrane receptor
US5851798A (en) * 1997-01-27 1998-12-22 Smithkline Beecham Corporation Nucleic acid encoding human GPR14 receptor
US6420526B1 (en) * 1997-03-07 2002-07-16 Human Genome Sciences, Inc. 186 human secreted proteins
WO1998039448A2 (en) 1997-03-07 1998-09-11 Human Genome Sciences, Inc. 186 human secreted proteins
JP2002536989A (ja) 1999-02-24 2002-11-05 メルク エンド カムパニー インコーポレーテッド ガラニン受容体と類似したｇタンパク質共役受容体
US20020077469A1 (en) * 1999-03-10 2002-06-20 Borowsky Beth E. DNA encoding orphan SNORF11 receptor
WO2004080479A1 (ja) * 2003-03-12 2004-09-23 Takeda Pharmaceutical Company Limited 性腺機能改善剤

Also Published As

Publication number Publication date
US20080131976A1 (en) 2008-06-05
JP2000312590A (ja) 2000-11-14
IL142428A0 (en) 2002-03-10
JP4486187B2 (ja) 2010-06-23
SK5502001A3 (en) 2002-01-07
DE69938666D1 (de) 2008-06-19
NZ510977A (en) 2002-10-25
WO2000024890A1 (en) 2000-05-04
NO20012059L (no) 2001-06-26
US20040180407A1 (en) 2004-09-16
EP1126028B1 (en) 2008-05-07
CN1324405A (zh) 2001-11-28
PL347553A1 (en) 2002-04-08
CA2347294A1 (en) 2000-05-04
ATE394485T1 (de) 2008-05-15
US6699965B1 (en) 2004-03-02
KR20010085974A (ko) 2001-09-07
AU6230699A (en) 2000-05-15
EP1126028A4 (en) 2002-11-27
US7608409B2 (en) 2009-10-27
ID28288A (id) 2001-05-10
US7314754B2 (en) 2008-01-01
CZ20011358A3 (cs) 2001-08-15
EP1126028A1 (en) 2001-08-22
HUP0104937A2 (hu) 2002-04-29
NO20012059D0 (no) 2001-04-26

Similar Documents

Publication Publication Date Title
BR9914835A (pt) Proteìna e seus sais, método para fabricar a mesma, anticorpo para a mesma, ligando à mesma, método para determinar o mesmo, peptìdeo parcial da proteìna ou seus ésteres ou suas amidas ou seus sais, polinucleotìdeo, vetor recombinante, transformante, composição de diagnóstico, composição farmacêutica, composto ou seus sais, método para triar o mesmo, kit para triar o mesmo, método para quantificar a proteìna, peptìdeo, uma amida deste, um éster deste ou um sal deste, amida ou sal do peptìdeo, método para triagem, e, kit para filtragem
Davletov et al. Isolation and biochemical characterization of a Ca2+-independent α-latrotoxin-binding protein
Frackowiak et al. Non-fibrillar β-amyloid protein is associated with smooth muscle cells of vessel walls in Alzheimer disease
DE69231473T2 (de) Immunochemischer nachweiss von endprodukten der fortgeschrittenen glycosylation in vivo
Mena et al. Staging the pathological assembly of truncated tau protein into paired helical filaments in Alzheimer’s disease
DE3650080T2 (de) Verfahren und Mittel zur Hemmung des Proteinveraltens.
JP5270337B2 (ja) 抗Ａβ抗体を精製する方法
DE10303974A1 (de) Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
DE69113273T2 (de) Zellnekrosnachweis durch prüfung von spektrin und seine abbauprodukte.
AT500379A2 (de) Tau-proteine
ATE131471T1 (de) An fette gebundene aminosäuren, peptide oder deren derivate
DE3751316T2 (de) Materialzusammensetzung, welche ein Polypeptid aus Pankreas-Insel-Amyloid und/oder Antikörpern gegen dieses Polypeptid enthält, und Anwendung dieser Zusammensetzung.
EP1353948B1 (de) Lösliche cyclische analoga des beta amyloiden peptids
Ringvold A preliminary report on the amino acid composition of the pseudo-exfoliation material (PE material)
EP0124896B1 (de) Verfahren zur Gewinnung von Viren bzw. Virusantigenen und deren Anwendung in Diagnose und Therapie (Impfstoff)
Aster et al. The 4.1-like proteins of the bovine lens: spectrin-binding proteins closely related in structure to red blood cell protein 4.1.
BAERT et al. Yolk protein in leech: identification, purification and characterization of vitellin and vitellogenin
DE60120782T2 (de) Bevorzugte segmente des ntp-proteins (neural thread protein) und verfahren zu deren verwendung
Vrdoljak et al. In vitro glycation of human immunoglobulin G
Kato et al. Gliotoxic effects of α-aminoadipic acid isomers on the carp retina: a long term observation
DE10230141A1 (de) Verfahren zur Anreicherung und zum Nachweis von veränderten Prion-Proteinen (PrPSc)
de Rosbo et al. Multiple sclerosis brain immunoglobulins stimulate myelin basic protein degradation in human myelin: a new cause of demyelination
Saito et al. Specific expression of an HNK-1 carbohydrate epitope and NCAM on femoral nerve Schwann cells in mice
DE69316388T2 (de) CRF Bindungsproteine
Veis Phosphoproteins from teeth and bone

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A, 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1913 DE 04/09/2007.